Clinical Catalysts
Pharmaceutical consultant focused on identifying potential biotech multibaggers. Not financial advice.
| Platform |  | Pricing | Only free issues | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 32 | Founded | 10 months ago | Last Issue | 18 days ago |
| Active | |||||
Read this Newsletter
clinicalcatalysts.substack.comLatest Issues
July's Biggest Biotech Catalysts
July brings another busy month for biotech, with several important regulatory catalysts approaching.
Each PDUFA date marks the culmination of years of research, clinical development and regulatory review.
For investors, these moments repl...
5 Lessons BIO 2026 Taught Me About Finding Biotech Multibaggers
Every June, the biotech industry comes together for one of its most important events: the BIO International Convention.
For four days, thousands of scientists, executives, investors and business development teams gather to discuss the tech...
This Biotech Is Up 90% Since My Original Thesis
Back in January, I wrote about uniQure (QURE) following one of the most dramatic sell-offs in biotech.
The stock had collapsed roughly 75% after the FDA unexpectedly pulled back from prior guidance around AMT-130, the company’s Huntington’...
The $800M Biotech Trying To Rewrite Cell Therapy (SANA)
For decades, medicine has learned how to replace what disease destroys.
New cells. New tissues. New possibilities.
The challenge has never been creating them. The challenge has been convincing the body to accept them.
Again and again, pr...
The Healthcare Infrastructure Company With Quiet Multibagger Potential (STVN)
Not every breakthrough in medicine comes from the molecule.
Some of it comes from how that molecule reaches the patient.
As therapies evolve, they are becoming harder to handle, store, and administer.
Precision is no longer optional.
Sm...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Clinical Catalysts.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Pharmaceutical consultant focused on identifying potential biotech multibaggers. Not financial advice.
Frequently Asked Questions
How can I access the email archive for Clinical Catalysts?
You can find recent issues that have been published by Clinical Catalysts on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Clinical Catalysts have?
To see how many people subscribe to Clinical Catalysts, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Clinical Catalysts?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Clinical Catalysts as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Clinical Catalysts?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Clinical Catalysts using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Clinical Catalysts?
Scroll up to where it says Related Newsletters to see other publications like Clinical Catalysts. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Clinical Catalysts?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.